Theragenics gets buyout offer from investment firm; shares jump

Mon May 13, 2013 10:01am EDT

May 13 (Reuters) - Medical device maker Theragenics Corp said it had received a takeover offer of $69.9 million to $71.4 million from Juniper Investment Co, representing a premium of 51-54 percent to its closing stock price on Friday.

The company's shares rose about 36 percent to $2.03 in early trading on the Nasdaq. Juniper Investments is offering $2.25 to $2.30 per share in cash, Theragenics said.

In a letter dated May 10, Juniper had offered Theragenics $2.05 to $2.10 per share. Theragenics said the latest offer represents a negotiated increase from the initial bid.

It also said it would negotiate exclusively with Juniper through June 11 regarding the acquisition. If the two reach a deal, Theragenics would seek interest from potential suitors through a "go shop" provision, the medical device maker said.

Theragenics is being advised by financial advisor VRA Partners and legal advisor Bryan Cave LLP.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.